Drugs / Ultra-rapid insulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04416737 | Nov 2021 → Jun 2023 | type 1 diabetes mellitus | Stanford University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ultra-rapid insulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04416737 ↗ |
| Route | Other | “inject ultra-rapid acting insulin into the upper and lower peritoneum” NCT04416737 ↗ |